Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol

Abstract Backgrounds To study the effects of supplementation of a marine omega-3 poly-unsaturated fatty acids (n3-PUFA) formulation (Omega3Q10) in older adults with hypertension and/or hypercholesterolemia. Methods A total of 97 people were enrolled to receive 12-week supplementation of either Omega...

Full description

Bibliographic Details
Main Authors: Tian Shen, Guoqiang Xing, Jingfen Zhu, Shuxian Zhang, Yong Cai, Donghua Li, Gang Xu, Evan Xing, Jianyu Rao, Rong Shi
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12944-017-0617-0
id doaj-14c04165140a4f93be5bc17ca7ea1191
record_format Article
spelling doaj-14c04165140a4f93be5bc17ca7ea11912020-11-24T21:46:34ZengBMCLipids in Health and Disease1476-511X2017-12-0116111110.1186/s12944-017-0617-0Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterolTian Shen0Guoqiang Xing1Jingfen Zhu2Shuxian Zhang3Yong Cai4Donghua Li5Gang Xu6Evan Xing7Jianyu Rao8Rong Shi9Department of Community Health and Behavior Medicine, School of Public Health, Shanghai Jiao Tong UniversityImaging Institute of Rehabilitation and Development of Brain Function, the Second Clinical Medical College of North Sichuan Medical College, Nanchong Central HospitalDepartment of Community Health and Behavior Medicine, School of Public Health, Shanghai Jiao Tong UniversityDepartment of Community Health and Behavior Medicine, School of Public Health, Shanghai Jiao Tong UniversityDepartment of Community Health and Behavior Medicine, School of Public Health, Shanghai Jiao Tong UniversityTang Qiao Community Health Service CenterDepartment of Community Health and Behavior Medicine, School of Public Health, Shanghai Jiao Tong UniversityBiochemistry Program, University of MarylandDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of CaliforniaSchool of Public Health, Shanghai University of Traditional Chinese MedicineAbstract Backgrounds To study the effects of supplementation of a marine omega-3 poly-unsaturated fatty acids (n3-PUFA) formulation (Omega3Q10) in older adults with hypertension and/or hypercholesterolemia. Methods A total of 97 people were enrolled to receive 12-week supplementation of either Omega3Q10 (n = 48) or soybean oil (n = 49). Total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and hypertension-related symptoms were determined before and after the supplementation. Results There were no baseline differences between the two groups. Omega3Q10 supplementation significantly reduced diastolic blood pressure (DBP) (from 81.6 ± 5.3 mmHg to 79.3 ± 5.2 mmHg, P < 0.05). Blood concentrations of TC and LDL-C decreased significantly and blood HDL-C level increased significantly after 12 weeks of Omega3Q10 (5.5 ± 0.7 vs. 5.3 ± 0.5, P < 0.05; 3.7 ± 0.8 vs. 3.3 ± 0.6, P < 0.05; 1.2 ± 0.6 vs. 1.3 ± 0.5, P < 0.05, respectively) and soybean oil supplementation (5.7 ± 0.8 vs. 5.6 ± 0.7, P < 0.05; 3.6 ± 0.7 vs. 3.4 ± 0.8, P < 0.05; 1.0 ± 0.8 vs. 1.2 ± 0.7, P < 0.05, respectively) but no group differences were found. A significantly greater proportion of the people in the Omega3Q10 group became free from headache and palpitations & chest tightness symptoms after the 12-week supplementation compared to that of the soybean oil group (95.5% vs. 71.4%, P < 0.01; 95.8 vs. 75.5%, P < 0.01, respectively). Conclusion 12-week supplementation of Fish oil-based PUFA appear to be more effective in improving DBP and hypertension-related symptoms than soybean oil in old adults with hypertension and hypercholesterolemia although both supplementation improved TC, LDL-C and HDL-C concentrations.http://link.springer.com/article/10.1186/s12944-017-0617-0Fish oil-derived PUFASoybean oilBlood pressures, Dyslipidemia, Old adults
collection DOAJ
language English
format Article
sources DOAJ
author Tian Shen
Guoqiang Xing
Jingfen Zhu
Shuxian Zhang
Yong Cai
Donghua Li
Gang Xu
Evan Xing
Jianyu Rao
Rong Shi
spellingShingle Tian Shen
Guoqiang Xing
Jingfen Zhu
Shuxian Zhang
Yong Cai
Donghua Li
Gang Xu
Evan Xing
Jianyu Rao
Rong Shi
Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
Lipids in Health and Disease
Fish oil-derived PUFA
Soybean oil
Blood pressures, Dyslipidemia, Old adults
author_facet Tian Shen
Guoqiang Xing
Jingfen Zhu
Shuxian Zhang
Yong Cai
Donghua Li
Gang Xu
Evan Xing
Jianyu Rao
Rong Shi
author_sort Tian Shen
title Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
title_short Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
title_full Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
title_fullStr Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
title_full_unstemmed Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol
title_sort effects of 12-week supplementation of marine omega-3 pufa-based formulation omega3q10 in older adults with prehypertension and/or elevated blood cholesterol
publisher BMC
series Lipids in Health and Disease
issn 1476-511X
publishDate 2017-12-01
description Abstract Backgrounds To study the effects of supplementation of a marine omega-3 poly-unsaturated fatty acids (n3-PUFA) formulation (Omega3Q10) in older adults with hypertension and/or hypercholesterolemia. Methods A total of 97 people were enrolled to receive 12-week supplementation of either Omega3Q10 (n = 48) or soybean oil (n = 49). Total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), and hypertension-related symptoms were determined before and after the supplementation. Results There were no baseline differences between the two groups. Omega3Q10 supplementation significantly reduced diastolic blood pressure (DBP) (from 81.6 ± 5.3 mmHg to 79.3 ± 5.2 mmHg, P < 0.05). Blood concentrations of TC and LDL-C decreased significantly and blood HDL-C level increased significantly after 12 weeks of Omega3Q10 (5.5 ± 0.7 vs. 5.3 ± 0.5, P < 0.05; 3.7 ± 0.8 vs. 3.3 ± 0.6, P < 0.05; 1.2 ± 0.6 vs. 1.3 ± 0.5, P < 0.05, respectively) and soybean oil supplementation (5.7 ± 0.8 vs. 5.6 ± 0.7, P < 0.05; 3.6 ± 0.7 vs. 3.4 ± 0.8, P < 0.05; 1.0 ± 0.8 vs. 1.2 ± 0.7, P < 0.05, respectively) but no group differences were found. A significantly greater proportion of the people in the Omega3Q10 group became free from headache and palpitations & chest tightness symptoms after the 12-week supplementation compared to that of the soybean oil group (95.5% vs. 71.4%, P < 0.01; 95.8 vs. 75.5%, P < 0.01, respectively). Conclusion 12-week supplementation of Fish oil-based PUFA appear to be more effective in improving DBP and hypertension-related symptoms than soybean oil in old adults with hypertension and hypercholesterolemia although both supplementation improved TC, LDL-C and HDL-C concentrations.
topic Fish oil-derived PUFA
Soybean oil
Blood pressures, Dyslipidemia, Old adults
url http://link.springer.com/article/10.1186/s12944-017-0617-0
work_keys_str_mv AT tianshen effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT guoqiangxing effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT jingfenzhu effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT shuxianzhang effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT yongcai effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT donghuali effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT gangxu effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT evanxing effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT jianyurao effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
AT rongshi effectsof12weeksupplementationofmarineomega3pufabasedformulationomega3q10inolderadultswithprehypertensionandorelevatedbloodcholesterol
_version_ 1725901273520144384